Repaglinide- Repide 05 Mg

Information About Repaglinide- Repide 05 Mg

About Repaglinide- Repide 05 Mg

The Medicine Brand Repide 05 mg is manufactured by Wallace Pharmaceuticals Ltd and mainly contents the generic drug Repaglinide.

Pakaging

10 Tablet

Active Ingredients For Repaglinide- Repide 05 Mg

Repaglinide 05 mg

Diseases List For Which Repaglinide- Repide 05 Mg Is Prescribed

This Drug Is Prescribed For Type II diabetes mellitus

Other Significations For Repaglinide- Repide 05 Mg

This Medication This medication is a thiazolidinedione antidiabetic prescribed for type 2 diabetes in certain patients It is used along with diet and exercise It may be used alone or with other antidiabetic medicines It lowers blood sugar by reducing insulin resistance

Precautions To Be Taken Before Repaglinide- Repide 05 Mg

Repaglinide is metabolized eliminated in the liver by an enzyme called CYP3A4 Drugs that affect this enzyme may affect the blood levels of repaglinide and thus alter its glucose lowering effect The metabolism of repaglinide may be prevented by ketoconazole Nizoralitraconazole Sporanox fluconazole Diflucan erythromycin EryTab andclarithromycin Biaxin As a result blood levels of repaglinide rise and there is an enhanced glucoselowering effect Dangerous hypoglycemic very low blood glucose reactions could occur On the other hand the elimination of repaglinide may be increased with drugs that increase levels of CYP3A4 in the liver such as barbiturates carbamazepine Tegretol and rifampin Rifadin This can result in lower blood levels of repaglinide andhyperglycemia high blood glucose

Major Conditions And Care

Pregnancy And Repaglinide- Repide 05 Mg

Can We Take Repaglinide- Repide 05 Mg During Pregnancy?

Pregnancy Class D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks

Lactation And Repaglinide- Repide 05 Mg

Can We Use Repaglinide- Repide 05 Mg During Lactation

Lactation Class L5 Studies in breastfeeding mothers have demonstrated that there is significant and documented risk to the infant based on human experience or it is a medication that has a high risk of causing significant damage to an infant The risk of using the drug in breastfeeding women clearly outweighs any possible benefit from breastfeeding The drug is contraindicated in women who are breastfeeding an infant

Side Effects Of Repaglinide- Repide 05 Mg

Nausea stomach upset skin rash acute toxicity

More Danger Effects Fatal Effect Due To Overdose Of Repaglinide- Repide 05 Mg